(Q42831772)

8 November 2017

Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes (English)

1 reference

8 November 2017

1 reference

6

Matthias Blüher

1 reference

8 November 2017

1

Mathias Fasshauer

1 reference

8 November 2017

3

Susan Kralisch

1 reference

8 November 2017

5

Ulrike Lössner

1 reference

8 November 2017

4

Margit Klier

1 reference

8 November 2017

7

Ralf Paschke

1 reference

8 November 2017

Johannes Klein

2

1 reference

PubMed ID

14759511

8 November 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

8 November 2017

1 reference

8 November 2017

558

1 reference

8 November 2017

27-32

1 reference

8 November 2017

1-3

1 reference

Obesity and insulin resistance

8 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The mouse homologue of the human acidic ribosomal phosphoprotein PO: a highly conserved polypeptide that is under translational control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Growth hormone signalling and its regulation: preventing too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Visceral obesity and the role of the somatotropic axis in the development of metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Cortisol and the metabolic syndrome in South Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Interleukin (IL)-6 mRNA Expression is Stimulated by Insulin, Isoproterenol, Tumour Necrosis Factor Alpha, Growth Hormone, and IL-6 in 3T3-L1 Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

The effect of in vivo thyroxine treatment on insulin receptors, glucose transport and GLUT4 in rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2901525-4

10.1016/S0014-5793(03)01525-4

7 January 2021

Identifiers

DOI

1 reference

8 November 2017

1 reference

PubMed ID

14759511